Stroke Clinical Trials

Find Stroke Clinical Trials Near You

Neuralert Stroke Monitor Trial

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The Neuralert monitoring system, a non-invasive device worn on each wrist, is designed to provide continuous monitoring and expedited recognition of stroke by identifying asymmetry in the extremities, facilitating patient treatment and improving outcomes. This study is designed to evaluate the safety and effectiveness of the Neuralert Monitor. This study aims to show that the device produces fewer than 2 false alarms per patient per day on average, and that the device detects stroke with a sensitivity significantly greater than a device producing 2 random alerts per day.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Healthy Volunteers: f
View:

• Male or female age ≥ 22 years

• Admitted or planned admission to one of the participating hospitals and followed by the Cardiothoracic (CT) Surgery or Vascular Surgery services

• Considered at high risk for stroke while in the hospital based on:

‣ Interventions or procedures that are high-risk for stroke performed during the hospitalization, which may include:

• Intracardiac surgical or endovascular procedures, including valve replacement

∙ Ascending aorta or aortic arch surgical or endovascular repair

∙ Open surgical or endovascular carotid revascularization

⁃ Other cardiac procedures along with a high-risk medical history:

• Age ≥ 80 years

∙ Prior stroke/ transient ischemic attack (TIA)

∙ Hypercoagulable state (i.e., prior clotting events attributed to active malignancy or a diagnosed thrombophilia) requiring lifelong anticoagulation

∙ Severely reduced left ventricular cardiac ejection fraction (i.e., \<30%) or anterior left ventricular wall akinesis

∙ Atrial fibrillation

Locations
United States
Pennsylvania
Hospital of the University of Pennsylvania
RECRUITING
Philadelphia
Contact Information
Primary
Brett Cucchiara, MD
cucchiar@pennmedicine.upenn.edu
(215) 662-6738
Time Frame
Start Date: 2026-03-26
Estimated Completion Date: 2028-07-15
Participants
Target number of participants: 1200
Treatments
Experimental: Cardiac Surgery Patients
Device: Neuralert Monitor Device to identify upper extremity asymmetry in patients who are high risk for stroke.
Related Therapeutic Areas
Sponsors
Leads: Neuralert Technologies LLC

This content was sourced from clinicaltrials.gov